Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)

SHA:600436 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	8,196	9,001	10,788	10,058	8,694	8,022
Revenue Growth	-22.06%	-16.56%	7.25%	15.70%	8.38%	23.20%
Gross Profit Gross Profit Growth	2,916	3,270	4,599	4,695	3,959	4,054
Operating Income Operating Income Growth	1,751	2,198	3,420	3,230	2,849	2,748
Net Income Net Income Growth	1,809	2,159	2,977	2,797	2,472	2,432
Earnings Per Share EPS Growth	3.00	3.58	4.93	4.64	4.10	4.03
EPS Growth	-32.89%	-27.38%	6.25%	13.17%	1.74%	45.49%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth	4,415	5,663	4,802	3,813	3,972
Offset of Business Segment Offset of Business Segment Growth	-1,408	-	-	-	-
Other Other Growth	243.99	256.78	322.95	168.63	44.89
Cosmetics Manufacturing Cosmetics Manufacturing Growth	660.09	752.07	706.76	634.3	841.35
Pharmaceutical Distribution Industry Pharmaceutical Distribution Industry Growth	5,090	4,084	4,205	4,059	3,146
Unallocated Other Unallocated Other Growth	-	31.87	22.31	19.52	17.29
Total Total Growth	9,001	10,788	10,058	8,694	8,022

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	3,644	2,548	5,008	10,173	8,698	7,106
Total Debt Total Debt Growth	1,034	1,062	1,148	1,166	1,109	885.21
Net Cash (Debt) Net Cash Growth	2,610	1,486	3,859	9,007	7,589	6,220
Net Cash Growth	-34.01%	-61.50%	-57.15%	18.67%	22.01%	39.78%
Net Cash Per Share Net Cash Per Share Growth	4.33	2.46	6.39	14.94	12.59	10.31

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	1,326	77.03	1,314	2,207	6,873	462.27
Capital Expenditures CapEx Growth	-566.07	-339.8	-1,068	-141.87	-175.37	-92.17
Free Cash Flow Free Cash Flow Growth	759.96	-262.77	245.41	2,065	6,698	370.11
Free Cash Flow Growth	508.70%	-	-88.11%	-69.17%	1709.66%	-64.69%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	35.58%	36.32%	42.63%	46.68%	45.54%	50.53%
Operating Margin	21.36%	24.42%	31.70%	32.11%	32.77%	34.25%
Pretax Margin	25.88%	28.19%	32.80%	33.49%	34.25%	35.77%
Profit Margin	22.08%	23.98%	27.60%	27.81%	28.44%	30.32%
FCF Margin	9.27%	-2.92%	2.27%	20.53%	77.04%	4.61%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	2.970	2.970	2.970	2.320	1.250	1.210
Dividend Per Share Growth	-51.24%	0%	28.02%	85.60%	3.31%	34.44%
Dividend Yield	2.42%	1.78%	1.42%	1.00%	0.45%	0.29%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	38.87	47.17	43.47	52.19	70.39	108.45
Forward PE	32.25	32.06	37.47	42.87	70.44	94.42
P/FCF Ratio	92.57	-	527.32	70.71	25.98	712.61
PS Ratio	8.58	11.31	12.00	14.52	20.02	32.88

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error